Tradestie Institutional Equity Comparison Engine

HIT vs DCM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HIT Overall Edge

HIT Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Health In Tech, Inc. Class A Common Stock (HIT) driven by superior Valuation, Growth & Margin while DCM counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, HIT trades at 8.8x Forward P/E with -45.8% operating margin (-22.4% YoY revenue) versus DCM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HIT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against DCM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner HIT
HIT 8.8x vs DCM N/M Fwd P/E
Growth & Margin Winner HIT
Op Margin -45.8% vs N/A ยท YoY -22.4% vs N/A
Momentum & Technical Winner DCM
1Y -72.3% vs -34.4% ยท 52W Pos 5% vs 0%
Options & Structure Winner DCM
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
HIT NASDAQ
Health In Tech, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.38
+12.36% 1D
Market Cap $27.1M
1M Return -33.48%
1Y Return -72.27%
Forward P/E 8.8x
Unified AI Score
39.6 / 100 SELL
Tech 48.0 Fund 45.0 Flow 50.0 Mom 45.0
DCM US Equity
DCM
Institutional Equity
$2.82
-6.62% 1D
Market Cap N/A
1M Return -26.75%
1Y Return -34.42%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HIT -72.27% DCM -34.42% Spread: +5.32 pp (DCM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HIT TTM Op. Margin: -45.8% DCM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HIT vs DCM. Trailing 12-month operating profitability (HIT -45.8% vs DCM N/A) and valuation multiples (HIT 8.8x vs DCM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HIT (8) vs DCM (2)
Institutional Metric HIT DCM Criterion Row Winner
Market Capitalization Scale $27.1M N/A Larger Scale HIT
Trailing P/E Ratio Valuation 8.8x N/M Lower Multiple HIT
Forward P/E Ratio Valuation 8.8x N/M Lower Multiple HIT
Revenue Growth (YoY) Growth -22.4% N/A Higher Growth HIT
Operating Margin (TTM) Profitability -45.8% N/A Higher Margin HIT
Net Profit Margin Profitability -37.1% N/A Higher Margin HIT
Return on Equity (ROE) Capital Efficiency -76.6% N/A Higher ROE HIT
52-Week Range Position Momentum 5% ($0โ€“$2) 0% ($3โ€“$5) Stronger Trend HIT
Beta / 30D Volatility Risk Regime 0.95ฮฒ ยท 152% Vol N/A Lower Realized Risk DCM
Unified Institutional Score Composite Signal 39.6 / 100 (SELL) 48.8 / 100 (HOLD) Higher Composite DCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HIT vs DCM Buy Guide
HIT BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HIT nor DCM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.